当前位置:首页 - 行情中心 - 天目药业(600671) - 财务分析 - 现金流量表

天目药业

(600671)

  

流通市值:23.83亿  总市值:23.84亿
流通股本:1.22亿   总股本:1.22亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金39,906,343234,985,355.88137,811,585.19108,552,386.91
  收到的税费返还-25,081.0925,081.09153.82
  收到其他与经营活动有关的现金2,525,846.0222,224,324.7216,321,184.8212,709,875.12
  经营活动现金流入小计42,432,189.02257,234,761.69154,157,851.1121,262,415.85
  购买商品、接受劳务支付的现金34,340,825.27148,909,690.64105,825,661.3371,649,239.04
  支付给职工以及为职工支付的现金11,498,161.2942,761,805.2731,625,825.820,757,435.21
  支付的各项税费5,729,674.6624,383,766.0222,524,848.4118,285,829.18
  支付其他与经营活动有关的现金10,293,040.9329,388,350.5225,012,604.3621,442,006.69
  经营活动现金流出小计61,861,702.15245,443,612.45184,988,939.9132,134,510.12
  经营活动产生的现金流量净额-19,429,513.1311,791,149.24-30,831,088.8-10,872,094.27
二、投资活动产生的现金流量:
  取得投资收益收到的现金-3,993.353,993.353,993.35
  处置固定资产、无形资产和其他长期资产收回的现金净额-22,76822,7685,154
  收到的其他与投资活动有关的现金-3,500,0013,500,0013,500,001
  投资活动现金流入的平衡项目-000
  投资活动现金流入小计-3,526,762.353,526,762.353,509,148.35
  购建固定资产、无形资产和其他长期资产支付的现金3,564,722.0631,176,853.4426,663,454.6619,607,620.51
  支付其他与投资活动有关的现金-3,500,0013,500,0013,500,001
  投资活动现金流出小计3,564,722.0634,676,854.4430,163,455.6623,107,621.51
  投资活动产生的现金流量净额-3,564,722.06-31,150,092.09-26,636,693.31-19,598,473.16
三、筹资活动产生的现金流量:
  吸收投资收到的现金-1,770,0001,770,0001,770,000
  其中:子公司吸收少数股东投资收到的现金--1,770,0001,770,000
  取得借款收到的现金102,353,973.65162,136,300118,752,80090,023,000
  筹资活动现金流入小计102,353,973.65163,906,300120,522,80091,793,000
  偿还债务支付的现金67,547,956144,727,14089,280,00084,280,000
  分配股利、利润或偿付利息支付的现金1,560,945.596,497,576.744,725,879.463,037,813.28
  支付其他与筹资活动有关的现金2,292,773.2514,509,984.0910,414,637.857,104,385.67
  筹资活动现金流出小计71,401,674.84165,734,700.83104,420,517.3194,422,198.95
  筹资活动产生的现金流量净额30,952,298.81-1,828,400.8316,102,282.69-2,629,198.95
五、现金及现金等价物净增加额7,958,063.62-21,187,343.68-41,365,499.42-33,099,766.38
  加:期初现金及现金等价物余额26,276,647.7947,463,991.4747,463,991.4747,463,991.47
  期末现金及现金等价物余额34,234,711.4126,276,647.796,098,492.0514,364,225.09
补充资料:
  净利润-7,202,945.17-6,397,830.43
  资产减值准备-1,657,052.82-494,501.47
  固定资产和投资性房地产折旧-14,301,112.85-7,123,374.13
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-14,301,112.85-7,123,374.13
  无形资产摊销-162,343.23-79,408.38
  长期待摊费用摊销-12,547,863.05-3,680,851.67
  处置固定资产、无形资产和其他长期资产的损失-11,714.52-6,675.6
  固定资产报废损失--241,401.25-653,041.9
  财务费用-7,198,209.47-3,257,961.5
  投资损失-1,708,564.94--3,993.35
  递延所得税--913,929.07--538,581.88
  其中:递延所得税资产减少--2,728,045.01-1,177,876.84
    递延所得税负债增加-1,814,115.94--1,716,458.72
  存货的减少-13,138,461.14-6,524,613.73
  经营性应收项目的减少--50,116,344.22--19,370,557.87
  经营性应付项目的增加--7,135,831.09--22,856,306.36
  融资租入固定资产-20,922,923.65-2,117,115.15
  现金的期末余额-26,276,647.79-14,364,225.09
  减:现金的期初余额-47,463,991.47-47,463,991.47
  现金及现金等价物的净增加额--21,187,343.68--33,099,766.38
公告日期2026-04-302026-04-182025-10-292025-08-28
审计意见(境内)标准无保留意见
TOP↑